Challenge
The MS market is crowded with many sizable competitors, all fighting for the same patients. Our client suffered a series of budget cuts that left the media budget at ~65% of the initial OOP contract value ($13M vs $20M), below the spending level of some of their more aggressive competitors.
A relatively small patient population, a complex MoA, and a boxed warning were further barriers to prescribing.
Solution
The educational programme is co-created with renowned experts, and is a forum for expert-led and peer-to-peer scientific exchange that culminates in an annual international summit. Resources are cascaded by client teams in national events, extending reach and driving continuous engagement. Focus is on supporting delegates to achieve behaviour-change goals and collecting associated programme metrics.
Outcome
The ongoing programme is now in its fifth successful year and has won both client-company and industry awards for excellence. Disease-specific metric dashboards clearly illustrate the impact of the programme on clinical behaviour and confidence each year.